{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:19:27Z","timestamp":1794809967275,"version":"4.9.1"},"reference-count":71,"publisher":"Bentham Science Publishers Ltd.","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2026,8,25]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Pancreatic cancer (PC) presents unique challenges to traditional immunotherapy\ndue to its immunosuppressive microenvironment and low mutation burden. Research\ninto antibody-mediated immune responses, which has been extensively applied in various\ncancer types, is also applicable to the study of pancreatic cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using public Genome-wide association study (GWAS) data and genetic instruments,\nwe conducted a two-sample Mendelian randomization (MR) analysis to explore causal relationships\nbetween 46 antibody-mediated immune responses and PC. We employed five MR methods.\nCochran\u2019s Q statistic and corresponding p-values from the MR Egger and Inverse Variance\nWeighted methods assessed instrument heterogeneity. Egger intercept and MR pleiotropy residual\nsum and outlier (MR-PRESSO) methods detected potential horizontal pleiotropy, ensuring the robustness\nof our findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our study identified causal links between five antibody-mediated immune responses and\npancreatic cancer risk. Chlamydia trachomatis momp A antibody levels were inversely correlated,\n\nwhile Anti-helicobacter pylori IgG seropositivity, Polyomavirus 2 JC VP1 antibody levels, and\nMerkel cell polyomavirus VP1 antibody levels showed positive correlations. Notably, Anti-\nMerkel cell polyomavirus IgG seropositivity exhibited strong positive associations across Inverse\nvariance weighting (IVW), weighted median, and MR-Egger analyses (p &lt; 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>These results suggest that specific Antibody-Mediated Immune Responses may modulate\npancreatic carcinogenesis through immune activation or chronic inflammation. The protective\nassociation for Chlamydia trachomatis momp A contrasts with the risk-enhancing effects observed\nfor anti-helicobacter pylori IgG and polyomaviruses, highlighting heterogeneous immunobiological\npathways that warrant mechanistic investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our study demonstrated a randomized causal effect between antibody-mediated immune\nresponses and pancreatic cancer, offering a new perspective for clinical diagnosis and treatment\nof the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715303396420251007140802","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:19:07Z","timestamp":1762240747000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Causal Links Between Antibody-Mediated Immune Responses and Pancreatic Cancer Risk"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9951-336X","authenticated-orcid":true,"given":"Xinyun","family":"zou","sequence":"first","affiliation":[{"name":"Department of Oncology, The General Hospital of Western Theater Command, Chengdu 610083, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2376-3468","authenticated-orcid":true,"given":"Yicheng","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Oncology, The General Hospital of Western Theater Command, Chengdu 610083, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The General Hospital of Western Theater Command, Chengdu 610083, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-8532","authenticated-orcid":true,"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The General Hospital of Western Theater Command, Chengdu 610083, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3419-5172","authenticated-orcid":true,"given":"Jinlan","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The General Hospital of Western Theater Command, Chengdu 610083, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"Siegel R.L.","year":"2023","unstructured":"Siegel R.L.; Miller K.D.; Wagle N.S.; Jemal A.; Cancer statistics, 2023. CA Cancer J Clin  2023,73(1),17-48","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H.","year":"2021","unstructured":"Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2021,71(3),209-249","journal-title":"CA Cancer J Clin"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"Halbrook C.J.","year":"2023","unstructured":"Halbrook C.J.; Lyssiotis C.A.; Pasca di Magliano M.; Maitra A.; Pancreatic cancer: Advances and challenges. Cell  2023,186(8),1729-1754","journal-title":"Cell"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13046-024-03166-w","volume":"43","author":"Reese K.L.","year":"2024","unstructured":"Reese K.L.; Pantel K.; Smit D.J.; Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer - A comprehensive review. J Exp Clin Cancer Res  2024,43(1),250","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-024-01561-6","volume":"17","author":"Farhangnia P.","year":"2024","unstructured":"Farhangnia P.; Khorramdelazad H.; Nickho H.; Delbandi A.A.; Current and future immunotherapeutic approaches in pancreatic cancer treatment. J Hematol Oncol  2024,17(1),40","journal-title":"J Hematol Oncol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S2468-1253(23)00207-8","volume":"8","author":"Hilmi M.","year":"2023","unstructured":"Hilmi M.; Delaye M.; Muzzolini M.; Nicolle R.; Cros J.; Hammel P.; Cardot-Ruffino V.; Neuzillet C.; The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy. Lancet Gastroenterol Hepatol  2023,8(12),1129-1142","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1383978","DOI":"10.3389\/fimmu.2024.1383978","volume":"15","author":"Zheng R.","year":"2024","unstructured":"Zheng R.; Liu X.; Zhang Y.; Liu Y.; Wang Y.; Guo S.; Jin X.; Zhang J.; Guan Y.; Liu Y.; Frontiers and future of immunotherapy for pancreatic cancer: From molecular mechanisms to clinical application. Front Immunol  2024,15,1383978","journal-title":"Front Immunol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13046-023-02935-3","volume":"43","author":"Luo W.","year":"2024","unstructured":"Luo W.; Wen T.; Qu X.; Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: Time to update the concept. J Exp Clin Cancer Res  2024,43(1),8","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.cell.2022.02.012","volume":"185","author":"Mazor R.D.","year":"2022","unstructured":"Mazor R.D.; Nathan N.; Gilboa A.; Stoler-Barak L.; Moss L.; Solomonov I.; Hanuna A.; Divinsky Y.; Shmueli M.D.; Hezroni H.; Zaretsky I.; Mor M.; Golani O.; Sabah G.; Jakobson-Setton A.; Yanichkin N.; Feinmesser M.; Tsoref D.; Salman L.; Yeoshoua E.; Peretz E.; Erlich I.; Cohen N.M.; Gershoni J.M.; Freund N.; Merbl Y.; Yaari G.; Eitan R.; Sagi I.; Shulman Z.; Tumor-reactive antibodies evolve from non-binding and autoreactive precursors. Cell  2022,185(7),1208-1222.e21","journal-title":"Cell"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/s41590-024-01890-1","volume":"25","author":"Lanahan S.M.","year":"2024","unstructured":"Lanahan S.M.; Yang L.; Jones K.M.; Qi Z.; Cabrera E.C.; Cominsky L.Y.; Ramaswamy A.; Barmada A.; Gabernet G.; Uthaya Kumar D.B.; Xu L.; Shan P.; Wymann M.P.; Kleinstein S.H.; Rao V.K.; Mustillo P.; Romberg N.; Abraham R.S.; Lucas C.L.; PI3K\u03b3 in B cells promotes antibody responses and generation of antibody-secreting cells. Nat Immunol  2024,25(8),1422-1431","journal-title":"Nat Immunol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","volume":"40","author":"Victora G.D.","year":"2022","unstructured":"Victora G.D.; Nussenzweig M.C.; Germinal centers. Annu Rev Immunol  2022,40(1),413-442","journal-title":"Annu Rev Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41577-023-00897-3","volume":"24","author":"Inoue T.","year":"2024","unstructured":"Inoue T.; Kurosaki T.; Memory B cells. Nat Rev Immunol  2024,24(1),5-17","journal-title":"Nat Rev Immunol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"825813","DOI":"10.3389\/fimmu.2021.825813","volume":"12","author":"Inoue T.","year":"2022","unstructured":"Inoue T.; Shinnakasu R.; Kurosaki T.; Generation of high quality memory B cells. Front Immunol  2022,12,825813","journal-title":"Front Immunol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1011776","DOI":"10.1371\/journal.pcbi.1011776","volume":"20","author":"Shin B.","year":"2024","unstructured":"Shin B.; An G.; Cockrell R.C.; Examining B-cell dynamics and responsiveness in different inflammatory milieus using an agent-based model. PLOS Comput Biol  2024,20(1),1011776","journal-title":"PLOS Comput Biol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s40259-023-00618-1","volume":"37","author":"Lee W.","year":"2023","unstructured":"Lee W.; Lee S.M.; Jung S.T.; Unlocking the power of complement-dependent cytotoxicity: Engineering strategies for the development of potent therapeutic antibodies for cancer treatments. BioDrugs  2023,37(5),637-648","journal-title":"BioDrugs"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1158\/2326-6066.CIR-14-0125","volume":"3","author":"Liu S.D.","year":"2015","unstructured":"Liu S.D.; Chalouni C.; Young J.C.; Junttila T.T.; Sliwkowski M.X.; Lowe J.B.; Afucosylated antibodies increase activation of Fc\u03b3RIIIa-dependent signaling components to intensify processes promoting ADCC. Cancer Immunol Res  2015,3(2),173-183","journal-title":"Cancer Immunol Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"172156","DOI":"10.1172\/JCI172156","volume":"133","author":"Chang H.L.","year":"2023","unstructured":"Chang H.L.; Schwettmann B.; McArthur H.L.; Chan I.S.; Antibody-drug conjugates in breast cancer: Overcoming resistance and boosting immune response. J Clin Invest  2023,133(18),172156","journal-title":"J Clin Invest"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"110602","DOI":"10.1016\/j.intimp.2023.110602","volume":"122","author":"Wu X.","year":"2023","unstructured":"Wu X.; Huang S.; He W.; Song M.; Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers. Int Immunopharmacol  2023,122,110602","journal-title":"Int Immunopharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","volume":"22","author":"Swain S.M.","year":"2023","unstructured":"Swain S.M.; Shastry M.; Hamilton E.; Targeting HER2-positive breast cancer: Advances and future directions. Nat Rev Drug Discov  2023,22(2),101-126","journal-title":"Nat Rev Drug Discov"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1186\/s12885-022-09772-1","volume":"22","author":"Lara S.","year":"2022","unstructured":"Lara S.; Heilig J.; Virtanen A.; Kleinau S.; Exploring complement-dependent cytotoxicity by rituximab isotypes in 2D and 3D-cultured B-cell lymphoma. BMC Cancer  2022,22(1),678","journal-title":"BMC Cancer"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13046-024-03238-x","volume":"44","author":"Carbone C.","year":"2025","unstructured":"Carbone C.; De Luca R.; Puca E.; Agostini A.; Caggiano A.; Priori L.; Esposito A.; Ascrizzi S.; Piro G.; Salvatore L.; De Sanctis F.; Ugel S.; Corbo V.; Neri D.; Tortora G.; Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice. J Exp Clin Cancer Res  2025,44(1),7","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13046-023-02868-x","volume":"42","author":"Wittwer N.L.","year":"2023","unstructured":"Wittwer N.L.; Brown M.P.; Liapis V.; Staudacher A.H.; Antibody drug conjugates: Hitting the mark in pancreatic cancer? J Exp Clin Cancer Res  2023,42(1),280","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"Davies N.M.","year":"2018","unstructured":"Davies N.M.; Holmes M.V.; Davey Smith G.; Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians. BMJ  2018,362,k601","journal-title":"BMJ"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s00125-023-05879-7","volume":"66","author":"Yuan S.","year":"2023","unstructured":"Yuan S.; Merino J.; Larsson S.C.; Causal factors underlying diabetes risk informed by Mendelian randomisation analysis: Evidence, opportunities and challenges. Diabetologia  2023,66(5),800-812","journal-title":"Diabetologia"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.21037\/tcr-24-1523","volume":"14","author":"Zou X.","year":"2025","unstructured":"Zou X.; Shen J.; Li X.; Diao Y.; Zhang L.; The causal effects of 2,821 protein level ratios on non-small cell lung cancer: A two-sample Mendelian randomization study. Transl Cancer Res  2025,14(2),1101-1110","journal-title":"Transl Cancer Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12876-023-02791-7","volume":"23","author":"Liu B.","year":"2023","unstructured":"Liu B.; Ye D.; Yang H.; Song J.; Sun X.; He Z.; Mao Y.; Hao G.; Assessing the relationship between gut microbiota and irritable bowel syndrome: A two-sample Mendelian randomization analysis. BMC Gastroenterol  2023,23(1),150","journal-title":"BMC Gastroenterol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/ije\/dyac149","volume":"52","author":"Spiga F.","year":"2023","unstructured":"Spiga F.; Gibson M.; Dawson S.; Tilling K.; Davey Smith G.; Munaf\u00f2 M.R.; Higgins J.P.T.; Tools for assessing quality and risk of bias in Mendelian randomization studies: A systematic review. Int J Epidemiol  2023,52(1),227-249","journal-title":"Int J Epidemiol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","volume":"2","author":"Sanderson E.","year":"2022","unstructured":"Sanderson E.; Glymour M.M.; Holmes M.V.; Kang H.; Morrison J.; Munaf\u00f2 M.R.; Palmer T.; Schooling C.M.; Wallace C.; Zhao Q.; Davey Smith G.; Mendelian randomization. Nat Rev Methods Primers  2022,2(1),6","journal-title":"Nat Rev Methods Primers"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"Emdin C.A.","year":"2017","unstructured":"Emdin C.A.; Khera A.V.; Kathiresan S.; Mendelian Randomization. JAMA  2017,318(19),1925-1926","journal-title":"JAMA"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10654-022-00874-5","volume":"37","author":"Yang Q.","year":"2022","unstructured":"Yang Q.; Sanderson E.; Tilling K.; Borges M.C.; Lawlor D.A.; Exploring and mitigating potential bias when genetic instrumental variables are associated with multiple non-exposure traits in Mendelian randomization. Eur J Epidemiol  2022,37(7),683-700","journal-title":"Eur J Epidemiol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"Kurki M.I.","year":"2023","unstructured":"Kurki M.I.; Karjalainen J.; Palta P.; Sipil\u00e4 T.P.; Kristiansson K.; Donner K.M.; Reeve M.P.; Laivuori H.; Aavikko M.; Kaunisto M.A.; Loukola A.; Lahtela E.; Mattsson H.; Laiho P.; Della Briotta Parolo P.; Lehisto A.A.; Kanai M.; Mars N.; R\u00e4m\u00f6 J.; Kiiskinen T.; Heyne H.O.; Veerapen K.; R\u00fceger S.; Lemmel\u00e4 S.; Zhou W.; Ruotsalainen S.; P\u00e4rn K.; Hiekkalinna T.; Koskelainen S.; Paajanen T.; Llorens V.; Gracia-Tabuenca J.; Siirtola H.; Reis K.; Elnahas A.G.; Sun B.; Foley C.N.; Aalto-Set\u00e4l\u00e4 K.; Alasoo K.; Arvas M.; Auro K.; Biswas S.; Bizaki-Vallaskangas A.; Carpen O.; Chen C.Y.; Dada O.A.; Ding Z.; Ehm M.G.; Eklund K.; F\u00e4rkkil\u00e4 M.; Finucane H.; Ganna A.; Ghazal A.; Graham R.R.; Green E.M.; Hakanen A.; Hautalahti M.; Hedman \u00c5.K.; Hiltunen M.; Hinttala R.; Hovatta I.; Hu X.; Huertas-Vazquez A.; Huilaja L.; Hunkapiller J.; Jacob H.; Jensen J.N.; Joensuu H.; John S.; Julkunen V.; Jung M.; Junttila J.; Kaarniranta K.; K\u00e4h\u00f6nen M.; Kajanne R.; Kallio L.; K\u00e4lvi\u00e4inen R.; Kaprio J.; Kerimov N.; Kettunen J.; Kilpel\u00e4inen E.; Kilpi T.; Klinger K.; Kosma V.M.; Kuopio T.; Kurra V.; Laisk T.; Laukkanen J.; Lawless N.; Liu A.; Longerich S.; M\u00e4gi R.; M\u00e4kel\u00e4 J.; M\u00e4kitie A.; Malarstig A.; Mannermaa A.; Maranville J.; Matakidou A.; Meretoja T.; Mozaffari S.V.; Niemi M.E.K.; Niemi M.; Niiranen T.; O\u00b4Donnell C.J.; Obeidat M.; Okafo G.; Ollila H.M.; Palom\u00e4ki A.; Palotie T.; Partanen J.; Paul D.S.; Pelkonen M.; Pendergrass R.K.; Petrovski S.; Pitk\u00e4ranta A.; Platt A.; Pulford D.; Punkka E.; Pussinen P.; Raghavan N.; Rahimov F.; Rajpal D.; Renaud N.A.; Riley-Gillis B.; Rodosthenous R.; Saarentaus E.; Salminen A.; Salminen E.; Salomaa V.; Schleutker J.; Serpi R.; Shen H.; Siegel R.; Silander K.; Siltanen S.; Soini S.; Soininen H.; Sul J.H.; Tachmazidou I.; Tasanen K.; Tienari P.; Toppila-Salmi S.; Tukiainen T.; Tuomi T.; Turunen J.A.; Ulirsch J.C.; Vaura F.; Virolainen P.; Waring J.; Waterworth D.; Yang R.; Nelis M.; Reigo A.; Metspalu A.; Milani L.; Esko T.; Fox C.; Havulinna A.S.; Perola M.; Ripatti S.; Jalanko A.; Laitinen T.; M\u00e4kel\u00e4 T.P.; Plenge R.; McCarthy M.; Runz H.; Daly M.J.; Palotie A.; FinnGen provides genetic insights from a well-phenotyped isolated population. Nature  2023,613(7944),508-518","journal-title":"Nature"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"ofaa450","DOI":"10.1093\/ofid\/ofaa450","volume":"7","author":"Butler-Laporte G.","year":"2020","unstructured":"Butler-Laporte G.; Kreuzer D.; Nakanishi T.; Harroud A.; Forgetta V.; Richards J.B.; Genetic determinants of antibody-mediated immune responses to infectious diseases agents: A genome-wide and HLA association study. Open Forum Infect Dis  2020,7(11),ofaa450","journal-title":"Open Forum Infect Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"166298","DOI":"10.1101\/166298","author":"Bycroft C.","year":"2017","unstructured":"Bycroft C.; Freeman C.; Petkeva D.; Band G.; Elliott L.T.; Sharp K.; Motyer A.; Vukcevic D.; Delameau O.; O'Lonnell J.; Lortes A.; Genome-wide genetic data on ~500,000 UK Biobank participants. bioRxiv  2017,166298","journal-title":"bioRxiv"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41467-019-14156-4","volume":"11","author":"Burgess S.","year":"2020","unstructured":"Burgess S.; Foley C.N.; Allara E.; Staley J.R.; Howson J.M.M.; A robust and efficient method for Mendelian randomization with hundreds of genetic variants. Nat Commun  2020,11(1),376","journal-title":"Nat Commun"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"19797","DOI":"10.1038\/s41598-025-05553-5","volume":"15","author":"Wu Z.","year":"2025","unstructured":"Wu Z.; Peng Q.; Ren Z.; Xu X.; Jiang X.; Yang W.; Han Y.; Oyang L.; Lin J.; Peng M.; Wu N.; Tang Y.; Liao Q.; Zhou Y.; Causal association between oral microbiota and oral cancer: A mendelian randomization study. Sci Rep  2025,15(1),19797","journal-title":"Sci Rep"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12916-024-03272-8","volume":"22","author":"Chen Y.","year":"2024","unstructured":"Chen Y.; Xie Y.; Ci H.; Cheng Z.; Kuang Y.; Li S.; Wang G.; Qi Y.; Tang J.; Liu D.; Li W.; Yang Y.; Plasma metabolites and risk of seven cancers: A two-sample Mendelian randomization study among European descendants. BMC Med  2024,22(1),90","journal-title":"BMC Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"Kamat M.A.","year":"2019","unstructured":"Kamat M.A.; Blackshaw J.A.; Young R.; Surendran P.; Burgess S.; Danesh J.; Butterworth A.S.; Staley J.R.; PhenoScanner V2: An expanded tool for searching human genotype-phenotype associations. Bioinformatics  2019,35(22),4851-4853","journal-title":"Bioinformatics"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1681\/ASN.2020121760","volume":"32","author":"Tin A.","year":"2021","unstructured":"Tin A.; K\u00f6ttgen A.; Mendelian randomization analysis as a tool to gain insights into causes of diseases: A primer. J Am Soc Nephrol  2021,32(10),2400-2407","journal-title":"J Am Soc Nephrol"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303380282250225071730","volume":"25","author":"Liu Y.Y.","year":"2025","unstructured":"Liu Y.Y.; Zhang Y.Y.; Wan Q.; Immunocytes play a crucial role as mediators in the protective effects of d-\u03b2-hydroxybutyrate dehydrogenase 1 against type 2 diabetes mellitus: A mendelian randomization study. Endocr Metab Immune Disord Drug Targets  2025,25","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"Bowden J.","year":"2015","unstructured":"Bowden J.; Smith D.G.; Burgess S.; Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int J Epidemiol  2015,44(2),512-525","journal-title":"Int J Epidemiol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1186\/s12888-023-05203-y","volume":"23","author":"Yu Y.","year":"2023","unstructured":"Yu Y.; Hou L.; Wu Y.; Yu Y.; Liu X.; Wu S.; He Y.; Ge Y.; Wei Y.; Qian F.; Luo Q.; Feng Y.; Cheng X.; Yu T.; Li H.; Xue F.; Causal associations between female reproductive behaviors and psychiatric disorders: A lifecourse Mendelian randomization study. BMC Psychiatry  2023,23(1),799","journal-title":"BMC Psychiatry"},{"key":"ref=42","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303378914250418095928","volume":"25","author":"Ye L.","year":"2025","unstructured":"Ye L.; Lin D.; Chen F.; Huang X.; Wu X.; Unraveling the lipidomic determinants of atrial fibrillation: An extensive mendelian randomization study. Endocr Metab Immune Disord Drug Targets  2025,25","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13048-023-01340-w","volume":"17","author":"Liu S.","year":"2024","unstructured":"Liu S.; Ding D.; Liu F.; Guo Y.; Xie L.; Han F.J.; Exploring the causal role of multiple metabolites on ovarian cancer: A two sample Mendelian randomization study. J Ovarian Res  2024,17(1),22","journal-title":"J Ovarian Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1007\/s12672-025-02997-z","volume":"16","author":"Liang G.","year":"2025","unstructured":"Liang G.; Wang L.; Wang Z.; Li T.; Jiang L.; Bai Y.; Yang L.; Feng Y.; Li Y.; Yang M.; Chang J.; Yang H.; Zhou X.; Duan L.; Ge C.; Causal association of antibody-mediated immune responses to infectious disease agents with lung cancer: A Mendelian randomization study. Discov Oncol  2025,16(1),1234","journal-title":"Discov Oncol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s12672-025-02250-7","volume":"16","author":"Ni P.","year":"2025","unstructured":"Ni P.; Li L.; Du K.; Nov P.; Wang D.; Wang C.; Kou Q.; Li Y.; Zhang Y.; Zheng C.; Fu W.; Li J.; Unveiling the immunological terrain of pancreatic ductal adenocarcinoma: Strategies to prompt immunotherapy from Mendelian randomization. Discov Oncol  2025,16(1),613","journal-title":"Discov Oncol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"105140","DOI":"10.1016\/j.ebiom.2024.105140","volume":"104","author":"Rosenkrands I.","year":"2024","unstructured":"Rosenkrands I.; Olsen A.W.; Knudsen S.; Dehari N.; Juel H.B.; Cheeseman H.M.; Andersen P.; Shattock R.J.; Follmann F.; Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccination. EBioMedicine  2024,104,105140","journal-title":"EBioMedicine"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41541-021-00312-9","volume":"6","author":"Olsen A.W.","year":"2021","unstructured":"Olsen A.W.; Rosenkrands I.; Holland M.J.; Andersen P.; Follmann F.; A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C\/C-related complex serovars. NPJ Vaccines  2021,6(1),58","journal-title":"NPJ Vaccines"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"141.12","DOI":"10.4049\/jimmunol.210.Supp.141.12","volume":"210","author":"Sahu R","year":"2023","unstructured":"Sahu R; Sipowe A C N; Chlamydia muridarumr ecombinant MOMP nanovaccine induces cross-reactive antibodies against Chlamydia trachomatishuman serovars. J Immunol  2023,210(1_Supplement),141.12-141.12","journal-title":"J Immunol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/ijc.32999","volume":"147","author":"Idahl A.","year":"2020","unstructured":"Idahl A.; Le Cornet C.; Gonz\u00e1lez Maldonado S.; Waterboer T.; Bender N.; Tj\u00f8nneland A.; Hansen L.; Boutron-Ruault M.C.; Fournier A.; Kvaskoff M.; Boeing H.; Trichopoulou A.; Valanou E.; Peppa E.; Palli D.; Agnoli C.; Mattiello A.; Tumino R.; Sacerdote C.; Onland-Moret N.C.; Gram I.T.; Weiderpass E.; Quir\u00f3s J.R.; Duell E.J.; S\u00e1nchez M.J.; Chirlaque M.D.; Barricarte A.; Gil L.; Br\u00e4ndstedt J.; Riesbeck K.; Lundin E.; Khaw K.T.; Perez-Cornago A.; Gunter M.J.; Dossus L.; Kaaks R.; Fortner R.T.; Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort. Int J Cancer  2020,147(8),2042-2052","journal-title":"Int J Cancer"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/jnci\/djy084","volume":"111","author":"Trabert B.","year":"2019","unstructured":"Trabert B.; Waterboer T.; Idahl A.; Brenner N.; Brinton L.A.; Butt J.; Coburn S.B.; Hartge P.; Hufnagel K.; Inturrisi F.; Lissowska J.; Mentzer A.; Peplonska B.; Sherman M.E.; Wills G.S.; Woodhall S.C.; Pawlita M.; Wentzensen N.; Antibodies against Chlamydia trachomatis and ovarian cancer risk in two independent populations. J Natl Cancer Inst  2019,111(2),129-136","journal-title":"J Natl Cancer Inst"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41416-020-0961-0","volume":"123","author":"Makkar R.","year":"2020","unstructured":"Makkar R.; Butt J.; Huang W.Y.; McGlynn K.A.; Koshiol J.; Pawlita M.; Waterboer T.; Freedman N.D.; Murphy G.; Seropositivity for Helicobacter pylori and hepatobiliary cancers in the PLCO study. Br J Cancer  2020,123(6),909-911","journal-title":"Br J Cancer"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.3390\/ijms24032895","volume":"24","author":"Salvatori S.","year":"2023","unstructured":"Salvatori S.; Marafini I.; Laudisi F.; Monteleone G.; Stolfi C.; Helicobacter pylori and gastric cancer: Pathogenetic mechanisms. Int J Mol Sci  2023,24(3),2895","journal-title":"Int J Mol Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/qjmed\/hcz157","volume":"112","author":"Liu I-L.","year":"2019","unstructured":"Liu I-L.; Tsai C.H.; Hsu C.H.; Hu J.M.; Chen Y.C.; Tian Y.F.; You S.L.; Chen C.Y.; Hsiao C.W.; Lin C.Y.; Chou Y.C.; Sun C.A.; Helicobacter pylori infection and the risk of colorectal cancer: A nationwide population-based cohort study. QJM  2019,112(10),787-792","journal-title":"QJM"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"0195264","DOI":"10.1371\/journal.pone.0195264","volume":"13","author":"Gong E.J.","year":"2018","unstructured":"Gong E.J.; Lee J.Y.; Bae S.E.; Park Y.S.; Choi K.D.; Song H.J.; Lee G.H.; Jung H.Y.; Jeong W.J.; Cheon G.J.; Yook J.H.; Kim B.S.; Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology. PLoS One  2018,13(4),0195264","journal-title":"PLoS One"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"e16243","DOI":"10.1200\/JCO.2021.39.15_suppl.e16243","volume":"39","author":"Otieno S.","year":"2021","unstructured":"Otieno S.; Jain A.L.; Mohammed O.; Patel J.R.; Collyer J.; Deleeuw P.; Husain A.; Weir A.B.; Positive association between Helicobacter pylori infection and pancreatic cancer: A case-control study. J Clin Oncol  2021,39(15_suppl)(Suppl.),e16243-e16243","journal-title":"J Clin Oncol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"S-322","DOI":"10.1016\/S0016-5085(19)37633-4","volume":"156","author":"Saleem S.","year":"2019","unstructured":"Saleem S.; Bleibel W.; Sa1346 - Association between helicobacter pylori infection and pancreatic cancer: A population-based study. Gastroenterology  2019,156(6),S-322","journal-title":"Gastroenterology"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"306ra151","DOI":"10.1126\/scitranslmed.aab1720","volume":"7","author":"Ray U.","year":"2015","unstructured":"Ray U.; Cinque P.; Gerevini S.; Longo V.; Lazzarin A.; Schippling S.; Martin R.; Buck C.B.; Pastrana D.V.; JC polyomavirus mutants escape antibody-mediated neutralization. Sci Transl Med  2015,7(306),306ra151","journal-title":"Sci Transl Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s13365-023-01164-w","volume":"29","author":"Rocchi A.","year":"2023","unstructured":"Rocchi A.; Sariyer I.K.; Berger J.R.; Revisiting JC virus and progressive multifocal leukoencephalopathy. J Neurovirol  2023,29(5),524-537","journal-title":"J Neurovirol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1074\/jbc.M109.064311","volume":"285","author":"Orba Y.","year":"2010","unstructured":"Orba Y.; Suzuki T.; Makino Y.; Kubota K.; Tanaka S.; Kimura T.; Sawa H.; Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling. J Biol Chem  2010,285(2),1544-1554","journal-title":"J Biol Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3390\/v12101192","volume":"12","author":"Saribas S.","year":"2020","unstructured":"Saribas S.; Safak M.; A comprehensive proteomics analysis of the JC virus (JCV) large and small tumor antigen interacting proteins: Large T primarily targets the host protein complexes with V-ATPase and ubiquitin ligase activities while small t mostly associates with those having phosphatase and chromatin-remodeling functions. Viruses  2020,12(10),1192","journal-title":"Viruses"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"976577","DOI":"10.3389\/fonc.2022.976577","volume":"12","author":"Zheng H.","year":"2022","unstructured":"Zheng H.; Xue H.; Zhang C.; The oncogenic roles of JC polyomavirus in cancer. Front Oncol  2022,12,976577","journal-title":"Front Oncol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"200298","DOI":"10.1016\/j.tvr.2024.200298","volume":"18","author":"Biffi R.","year":"2024","unstructured":"Biffi R.; Benoit S.W.; Sariyer I.K.; Safak M.; JC virus small tumor antigen promotes S phase entry and cell cycle progression. Tumour Virus Res  2024,18,200298","journal-title":"Tumour Virus Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13027-017-0122-0","volume":"12","author":"Delbue S.","year":"2017","unstructured":"Delbue S.; Comar M.; Ferrante P.; Review on the role of the human Polyomavirus JC in the development of tumors. Infect Agent Cancer  2017,12(1),10","journal-title":"Infect Agent Cancer"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1743-422X-7-42","volume":"7","author":"Coelho T.R.","year":"2010","unstructured":"Coelho T.R.; Almeida L.; Lazo P.A.; JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process? Virol J  2010,7(1),42","journal-title":"Virol J"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"676627","DOI":"10.3389\/fimmu.2021.676627","volume":"12","author":"Mazziotta C.","year":"2021","unstructured":"Mazziotta C.; Lanzillotti C.; Torreggiani E.; Oton-Gonzalez L.; Iaquinta M.R.; Mazzoni E.; Gaboriaud P.; Touz\u00e9 A.; Silvagni E.; Govoni M.; Martini F.; Tognon M.; Rotondo J.C.; Serum antibodies against the oncogenic merkel cell polyomavirus detected by an innovative immunological assay with mimotopes in healthy subjects. Front Immunol  2021,12,676627","journal-title":"Front Immunol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"7998","DOI":"10.3390\/ijms21217998","volume":"21","author":"Prezioso C.","year":"2020","unstructured":"Prezioso C.; Bianchi M.; Obregon F.; Ciotti M.; Sarmati L.; Andreoni M.; Palamara A.T.; Pascarella S.; Moens U.; Pietropaolo V.; Structural analysis of merkel cell polyomavirus (MCPyV) viral capsid protein 1 (VP1) in HIV-1 infected individuals. Int J Mol Sci  2020,21(21),7998","journal-title":"Int J Mol Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12985-024-02395-x","volume":"21","author":"Thevenin K.R.","year":"2024","unstructured":"Thevenin K.R.; Tieche I.S.; Di Benedetto C.E.; Schrager M.; Dye K.N.; The small tumor antigen of Merkel cell polyomavirus accomplishes cellular transformation by uniquely localizing to the nucleus despite the absence of a known nuclear localization signal. Virol J  2024,21(1),125","journal-title":"Virol J"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1010551","DOI":"10.1371\/journal.ppat.1010551","volume":"18","author":"Spurgeon M.E.","year":"2022","unstructured":"Spurgeon M.E.; Cheng J.; Ward-Shaw E.; Dick F.A.; DeCaprio J.A.; Lambert P.F.; Merkel cell polyomavirus large T antigen binding to pRb promotes skin hyperplasia and tumor development. PLoS Pathog  2022,18(5),1010551","journal-title":"PLoS Pathog"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/2767-9764.CRC-22-0211","volume":"2","author":"Soikkeli A.I.","year":"2022","unstructured":"Soikkeli A.I.; Kyl\u00e4niemi M.K.; Sihto H.; Alinikula J.; Oncogenic merkel cell polyomavirus T antigen truncating mutations are mediated by APOBEC3 activity in merkel cell carcinoma. Cancer Res Commun  2022,2(11),1344-1354","journal-title":"Cancer Res Commun"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/genes15091127","volume":"15","author":"Myrda J.","year":"2024","unstructured":"Myrda J.; Bremm F.; Schaft N.; D\u00f6rrie J.; The role of the large T antigen in the molecular pathogenesis of merkel cell carcinoma. Genes  2024,15(9),1127","journal-title":"Genes"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"e01610-17","DOI":"10.1128\/JVI.01610-17","volume":"92","author":"Liu W.","year":"2018","unstructured":"Liu W.; Krump N.A.; MacDonald M.; You J.; Merkel Cell Polyomavirus Infection of Animal Dermal Fibroblasts. J Virol  2018,92(4),e01610-17","journal-title":"J Virol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/247147","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/247147\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/247147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:02:33Z","timestamp":1794808953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/247147\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":71,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715303396420251007140802","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e18715303396420"}}